{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:23Z","timestamp":1791176003629,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Probiotic supplementation has been investigated as a potential adjunctive treatment for depressive disorders, but its clinical efficacy and safety remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of probiotics on depressive symptom severity, clinical response, remission, treatment discontinuation, and adverse events in adults with clinically diagnosed depressive disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to May 8, 2026. Randomized controlled trials (RCTs) evaluating orally administered probiotics against placebo or another non-probiotic control were included. Continuous outcomes were summarized as standardized mean differences (SMDs) using Hedges\u2019 g, and dichotomous outcomes as risk ratios (RRs), with 95% confidence intervals (CIs). Random-effects models used restricted maximum likelihood estimation with Hartung\u2013Knapp adjustment. Heterogeneity was assessed using Cochran\u2019s Q, I\n                      <jats:sup>2<\/jats:sup>\n                      , and \u03c4\n                      <jats:sup>2<\/jats:sup>\n                      , and robustness was examined using leave-one-out sensitivity analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine RCTs involving 460 participants were included. Probiotic supplementation was associated with a modest reduction in depressive symptom severity (SMD, \u22120.43; 95% CI, \u22120.73 to \u22120.12; I\n                      <jats:sup>2<\/jats:sup>\n                      = 46.8%; \u03c4\n                      <jats:sup>2<\/jats:sup>\n                      = 0.069). The 95% prediction interval ranged from \u22121.10 to 0.25. Leave-one-out estimates ranged from \u22120.52 to \u22120.38, with all 95% CIs excluding zero. No significant effect modification was detected across formulation, dose, duration, treatment context, diagnostic population, or outcome-rater subgroups. Clinical response and remission were available from one trial and remained inconclusive (RR, 0.75; 95% CI, 0.32\u20131.77; and RR, 0.42; 95% CI, 0.08\u20132.19, respectively). All-cause discontinuation did not differ clearly between groups (seven RCTs; RR, 1.15; 95% CI, 0.67\u20131.98). Adverse-event evidence was limited and inconsistently reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotic supplementation may modestly reduce depressive symptom severity, particularly as an adjunct to established treatment. However, the prediction interval included the null, and evidence regarding clinical response, remission, and safety remained inconclusive. Larger, adequately powered RCTs with standardized clinically meaningful outcomes and strain-specific reporting are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1900466","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:36:20Z","timestamp":1791174980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effects of probiotic supplementation on depressive symptom severity in adults with depressive disorders: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"You-Sheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition and Metabolic Diseases, Shijiazhuang People\u2019s Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Shuang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Metabolic Diseases, Shijiazhuang People\u2019s Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shijiazhuang People\u2019s Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, The Third Hospital of Shijiazhuang, Shijiazhuang","place":["Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management.","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/brainsci15050525","article-title":"Physical, cognitive, social, and functional health correlates of major depressive disorder subtypes: a systematic review.","volume":"15","author":"McKeough","year":"2025","journal-title":"Brain Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43556-024-00205-y","article-title":"Treatment-resistant depression: molecular mechanisms and management.","volume":"5","author":"Kajumba","year":"2024","journal-title":"Mol Biomed"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.3390\/nu12082315","article-title":"Lactobacillus plantarum PS128 improves physiological adaptation and performance in triathletes through gut microbiota modulation.","volume":"12","author":"Huang","year":"2020","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/cells13171436","article-title":"Gut-brain axis: role of microbiome, metabolomics, hormones, and stress in mental health disorders.","volume":"13","author":"Verma","year":"2024","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","first-page":"104527","DOI":"10.1016\/j.ebiom.2023.104527","article-title":"Gut microbiota and its metabolites in depression: from pathogenesis to treatment.","volume":"90","author":"Liu","year":"2023","journal-title":"EBioMedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1186\/s12967-025-07176-w","article-title":"Do immune system and microbiome-gut-brain axis interactions associate with major depressive disorder?","volume":"23","author":"Zhao","year":"2025","journal-title":"J Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"591429","DOI":"10.2147\/NDT.S591429","article-title":"Imbalance of the brain-gut-microbiota axis in major depressive disorder: from pathogenesis to clinical translation.","volume":"22","author":"Wu","year":"2026","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1793292","DOI":"10.3389\/fphar.2026.1793292","article-title":"Targeting the gut-immune-brain axis: pharmacological insights from depression in inflammatory bowel disease.","volume":"17","author":"Sim\u00f5es","year":"2026","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2174\/0113892010281892240116081031","article-title":"The gut microbiota and major depressive disorder: current understanding and novel therapeutic strategies.","volume":"25","author":"Bahmani","year":"2024","journal-title":"Curr Pharm Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41398-023-02670-5","article-title":"Gut microbiota composition in depressive disorder: a systematic review, meta-analysis, and meta-regression.","volume":"13","author":"Gao","year":"2023","journal-title":"Transl Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1163\/18762891-bja00053","article-title":"Deciphering the role of probiotics in mental health: a systematic literature review of psychobiotics.","volume":"16","author":"Hussain","year":"2024","journal-title":"Benef Microbes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e4698","DOI":"10.1002\/fsn3.4698","article-title":"Effects of probiotics as adjunctive therapy to fluoxetine on depression severity and serum brain-derived neurotrophic factor, cortisol, and adrenocorticotropic hormone in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.","volume":"13","author":"Elahinejad","year":"2025","journal-title":"Food Sci Nutr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41398-022-01977-z","article-title":"Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial.","volume":"12","author":"Schaub","year":"2022","journal-title":"Transl Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1504","DOI":"10.1093\/nutrit\/nuae177","article-title":"Effects of Prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: systematic review and meta-analysis of randomized controlled trials.","volume":"83","author":"Asad","year":"2025","journal-title":"Nutr Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12888-026-08097-8","article-title":"Alterations of short-chain fatty acids in depression and effects of probiotics\/prebiotics interventions on levels and clinical symptoms: a systematic review and meta-analysis.","volume":"26","author":"Li","year":"2026","journal-title":"BMC Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/jcm10040647","article-title":"Updated review and meta-analysis of probiotics for the treatment of clinical depression: adjunctive vs. stand-alone treatment.","volume":"10","author":"Nikolova","year":"2021","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/ph19010156","article-title":"\u201cAttacking\u201d the gut-brain axis with psychobiotics: an umbrella review of depressive and anxiety symptoms.","volume":"19","author":"S\u00e1 Filho","year":"2026","journal-title":"Pharmaceuticals"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","article-title":"A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia.","volume":"27","author":"McGuinness","year":"2022","journal-title":"Mol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104210","DOI":"10.1016\/j.ajp.2024.104210","article-title":"The effects of Lactobacillus plantarum PS128 in patients with major depressive disorder: an eight-week double-blind, placebo-controlled study.","volume":"101","author":"Lin","year":"2024","journal-title":"Asian J Psychiatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/nu16091389","article-title":"Metabolic status influences probiotic efficacy for depression-PRO-DEMET randomized clinical trial results.","volume":"16","author":"Gawlik-Kotelnicka","year":"2024","journal-title":"Nutrients"},{"key":"B24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamapsychiatry.2023.1817","article-title":"Acceptability, tolerability, and estimates of putative treatment effects of probiotics as adjunctive treatment in patients with depression: a randomized clinical trial.","volume":"80","author":"Nikolova","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2021.11.023","article-title":"Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: a randomized clinical trial.","volume":"100","author":"Tian","year":"2022","journal-title":"Brain Behav Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","article-title":"Probiotic lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study.","volume":"100","author":"Rudzki","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.clnu.2018.04.010","article-title":"Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial.","volume":"38","author":"Kazemi","year":"2019","journal-title":"Clin Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nut.2015.09.003","article-title":"Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.","volume":"32","author":"Akkasheh","year":"2016","journal-title":"Nutrition"},{"key":"B29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/microorganisms12020411","article-title":"Probiotics\u2019 effects in the treatment of anxiety and depression: a comprehensive review of 2014-2023 clinical trials.","volume":"12","author":"Merkouris","year":"2024","journal-title":"Microorganisms"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.3390\/molecules28073213","article-title":"The role of probiotics and their metabolites in the treatment of depression.","volume":"28","author":"Jach","year":"2023","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2423241","DOI":"10.1001\/jamanetworkopen.2024.23241","article-title":"Heterogeneity of treatment effects in internet- and mobile-based interventions for depression: a systematic review and meta-analysis.","volume":"7","author":"Terhorst","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1017\/rsm.2025.10055","article-title":"Assessing the properties of the prediction interval in random-effects meta-analysis.","volume":"17","author":"M\u00e1trai","year":"2026","journal-title":"Res Synth Methods"},{"key":"B33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4097\/kja.25001","article-title":"Heterogeneity in meta-analyses: an unavoidable challenge worth exploring.","volume":"78","author":"Choi","year":"2025","journal-title":"Korean J Anesthesiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jtho.2020.12.008","article-title":"Statistical considerations for subgroup analyses.","volume":"16","author":"Wang","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcpt.13791","article-title":"Biases in reporting of adverse effects in clinical trials, and potential impact on safety assessments in systematic reviews and therapy guidelines.","volume":"131","author":"Westergren","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1608238","DOI":"10.3389\/fpsyt.2025.1608238","article-title":"Efficacy of probiotic intervention in unmedicated depression: a systematic review and meta-analysis.","volume":"16","author":"Haiyan","year":"2026","journal-title":"Front Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"106554","DOI":"10.1016\/j.clnu.2025.106554","article-title":"Effectiveness of probiotic supplementation in managing depressive symptoms and inflammatory status in patients with depression: a systematic review and meta-analysis.","volume":"58","author":"Shakir Shakir","year":"2026","journal-title":"Clin Nutr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/nutrit\/nuad171","article-title":"Probiotics for adults with major depressive disorder compared with antidepressants: a systematic review and network meta-analysis.","volume":"83","author":"Zhao","year":"2025","journal-title":"Nutr Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13099-024-00634-8","article-title":"Strain-specific effects of probiotics on depression and anxiety: a meta-analysis.","volume":"16","author":"Rahmannia","year":"2024","journal-title":"Gut Pathog"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1900466\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:36:28Z","timestamp":1791174988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1900466\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":39,"alternative-id":["10.3389\/fnut.2026.1900466"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1900466","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1900466"}}